The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Oct. 22, 2024
Filed:
May. 12, 2021
Applicants:
Saint Louis University, St. Louis, MO (US);
Research Foundation of the City University of New York, New York, NY (US);
Inventors:
John Edwin Tavis, Kirkwood, MO (US);
Amelia Pinto, St. Louis, MO (US);
James Brien, St. Louis, MO (US);
Ryan Murelli, Belleville, NJ (US);
Assignees:
Saint Louis University, St. Louis, MO (US);
Research Foundation of the City University of New York, New York, NY (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/122 (2006.01); A61K 31/165 (2006.01); A61K 31/215 (2006.01); A61K 31/341 (2006.01); A61K 31/381 (2006.01); A61K 31/4412 (2006.01); A61K 31/454 (2006.01); A61P 31/14 (2006.01);
U.S. Cl.
CPC ...
A61K 31/122 (2013.01); A61K 31/165 (2013.01); A61K 31/215 (2013.01); A61K 31/341 (2013.01); A61K 31/381 (2013.01); A61K 31/4412 (2013.01); A61K 31/454 (2013.01); A61P 31/14 (2018.01);
Abstract
The present disclosure provides inhibitors of bunyavirus of the formula: wherein the variables are defined herein. These inhibitors may be used to treat an infection of Rift Valley phlebovirus, hantavirus, and La Crosse virus, or Crimean-Congo Hemorrhagic fever.